SEOM clinical guidelines on venous thromboembolism (VTE) and cancer (2023)

被引：2

作者：

Moran, Laura Ortega ^{[1
]}

Mateo, Francisco Jose Pelegrin ^{[2
]}

Balanya, Rut Porta ^{[3
]}

Revuelta, Jacobo Rogado ^{[4
]}

Martinez, Silverio Ros ^{[5
]}

Fombella, Jose Pablo Berros ^{[6
]}

Vazquez, Elena Maria Brozos ^{[7
]}

Caro, Natalia Luque ^{[8
]}

Langa, Jose Munoz ^{[9
]}

Fernandez, Mercedes Salgado ^{[10
]}

机构：

[1] Hosp Gen Univ Gregorio Maranon, Inst Invest Sanitaria Gregorio Maranon, Madrid, Spain

[2] Hosp St Creu i St Pau, Barcelona, Spain

[3] Hosp Universitari Dr Josep Trueta, ICO Girona, Hosp Universitari Dr, Girona, Spain

[4] Hosp Univ Infanta Leonor, Madrid, Spain

[5] Hosp Univ Virgen Arrixaca, Murcia, Spain

[6] Hosp Univ San Agustin, Aviles, Asturias, Spain

[7] Complexo Hosp Univ A Coruna, La Coruna, Spain

[8] Hosp Univ Jaen, Jaen, Spain

[9] Hosp Arnau Vilanova, Valencia, Spain

[10] Complexo Hosp Univ Ourense, Orense, Spain

来源：

CLINICAL & TRANSLATIONAL ONCOLOGY | 2024年 / 26卷 / 11期

关键词：

Venous thromboembolism; Cancer; Anticoagulation; Guidelines; Low-molecular-weight heparins; Direct oral anticoagulants; MOLECULAR-WEIGHT HEPARIN; DEEP-VEIN THROMBOSIS; DIRECT ORAL ANTICOAGULANTS; PLACEBO-CONTROLLED TRIAL; PHASE-III TRIAL; MEDICAL PATIENTS; EXTENDED THROMBOPROPHYLAXIS; AMBULATORY PATIENTS; PULMONARY-EMBOLISM; LAPAROSCOPIC SURGERY;

D O I：

10.1007/s12094-024-03605-2

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The Spanish Society of Medical Oncology (SEOM) last published clinical guidelines on venous thromboembolism (VTE) and cancer in 2019, with a partial update in 2020. In this new update to the guidelines, SEOM seeks to incorporate recent evidence, based on a critical review of the literature, to provide practical current recommendations for the prophylactic and therapeutic management of VTE in patients with cancer. Special clinical situations whose management and/or choice of currently recommended therapeutic options (low-molecular-weight heparins [LMWHs] or direct-acting oral anticoagulants [DOACs]) is controversial are included.

引用

页码：2877 / 2901

页数：25

共 145 条

[71] Venous thromboembolism in patients with hematologic malignancy and thrombocytopenia [J].

Khanal, Nabin ;

Bociek, R. Gregory ;

Chen, Baojiang ;

Vose, Julie M. ;

Armitage, James O. ;

Bierman, Philip J. ;

Maness, Lori J. ;

Lunning, Matthew A. ;

Gundabolu, Krishna ;

Bhatt, Vijaya R. .

AMERICAN JOURNAL OF HEMATOLOGY, 2016, 91 (11) :E468-E472

[72] Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer [J].

Khorana, A. A. ;

Soff, G. A. ;

Kakkar, A. K. ;

Vadhan-Raj, S. ;

Riess, H. ;

Wun, T. ;

Streiff, M. B. ;

Garcia, D. A. ;

Liebman, H. A. ;

Belani, C. P. ;

O'Reilly, E. M. ;

Patel, J. N. ;

Yimer, H. A. ;

Wildgoose, P. ;

Burton, P. ;

Vijapurkar, U. ;

Kaul, S. ;

Eikelboom, J. ;

McBane, R. ;

Bauer, K. A. ;

Kuderer, N. M. ;

Lyman, G. H. .

NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (08) :720-728

[73]

Klok FA, 2020, THROMB RES, V191, P145, DOI [10.1016/j.thromres.2020.04.013, 10.1016/j.thromres.2020.04.041]

[74] Extended thromboprophylaxis following major abdominal/pelvic cancer-related surgery: A systematic review and meta-analysis of the literature [J].

Knoll, William ;

Fergusson, Nathan ;

Ivankovic, Victoria ;

Wang, Tzu-Fei ;

Caiano, Lucia ;

Auer, Rebecca ;

Carrier, Marc .

THROMBOSIS RESEARCH, 2021, 204 :114-122

[75] Management and outcomes of cancer-associated venous thromboembolism in patients with concomitant thrombocytopenia: a retrospective cohort study [J].

Kopolovic, Ilana ;

Lee, Agnes Y. Y. ;

Wu, Cynthia .

ANNALS OF HEMATOLOGY, 2015, 94 (02) :329-336

[76] A Prospective Study of Apixaban for Central Venous Catheter Associated Upper Extremity Deep Vein Thrombosis in Cancer Patients: Catheter 3 [J].

Kovacs, Michael J. ;

Wells, Philip S. ;

Rodger, Marc A. ;

Carrier, Marc ;

Yeo, Erik ;

Kovacs, Judy A. ;

Lazo-Langner, Alejandro .

BLOOD, 2022, 140 :1245-1246

[77] Risk factors for venous thromboembolic events in cancer patients [J].

Kröger, K ;

Weiland, D ;

Ose, C ;

Neumann, N ;

Weiss, S ;

Hirsch, C ;

Urbanski, K ;

Seeber, S ;

Scheulen, ME .

ANNALS OF ONCOLOGY, 2006, 17 (02) :297-303

[78] Catheter-related thrombosis (CRT) in patients with solid tumors: a narrative review and clinical guidance for daily care [J].

Laguna, Juan Carlos ;

Cooksley, Tim ;

Ahn, Shin ;

Tsoukalas, Nikolaos ;

Oo, Thein Hlaing ;

Brito-Dellan, Norman ;

Esposito, Francis ;

Escalante, Carmen ;

Font, Carme .

SUPPORTIVE CARE IN CANCER, 2022, 30 (10) :8577-8588

[79] Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer [J].

Lee, AYY ;

Levine, MN ;

Baker, RI ;

Bowden, C ;

Kakkar, AK ;

Prins, M ;

Rickles, FR ;

Julian, JA ;

Haley, S ;

Kovacs, MJ ;

Gent, M .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (02) :146-153

[80] Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients [J].

Leizorovicz, A ;

Cohen, AT ;

Turpie, AGG ;

Olsson, CG ;

Vaitkus, PT ;

Goldhaber, SZ .

CIRCULATION, 2004, 110 (07) :874-879

← 3 4 5 6 7 8 9 10 11 12 →